Biomea Fusion, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
Mailing Address 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
Phone (650) 980-9099
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2025
-$61.80M
Net Income
$51.57M
Stockholders' Equity
$176.87M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 24, 2026 | View on SEC |
| 8-K Current report of material events | March 24, 2026 | View on SEC |
| 8-K Current report of material events | February 25, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 12, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 6, 2026 | View on SEC |
| 5 Annual insider ownership changes | February 6, 2026 | View on SEC |
| 8-K Current report of material events | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | December 15, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | December 8, 2025 | View on SEC |
Annual Reports
10-K March 24, 2026
- Advancement of the FUSION™ platform and lead drug candidate BMF-219.
- Early clinical data indicates potential for long-term blood sugar management.
Insider Trading
BUY 2 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.